{{Rsnum
|rsid=2082940
|Gene=ADIPOQ
|Chromosome=3
|position=186856375
|Orientation=plus
|GMAF=0.1924
|Gene_s=ADIPOQ,ADIPOQ-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.6 | 20.4 | 0.0
| HCB | 52.6 | 41.4 | 6.0
| JPT | 54.5 | 39.1 | 6.4
| YRI | 60.0 | 31.0 | 9.0
| ASW | 70.2 | 28.1 | 1.8
| CHB | 52.6 | 41.4 | 6.0
| CHD | 51.9 | 38.7 | 9.4
| GIH | 77.8 | 21.2 | 1.0
| LWK | 55.0 | 34.9 | 10.1
| MEX | 74.1 | 22.4 | 3.4
| MKK | 56.3 | 38.4 | 5.3
| TSI | 69.6 | 28.4 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21960694
|Title=Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer
|OA=1
}}

{{PMID Auto
|PMID=21219602
|Title=Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study.
|OA=1
}}

{{PMID Auto
|PMID=24894086
|Title=Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes
}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}